Tag: KNTE

On November 17, 2023, Kinnate Biopharma's shares saw a surge in trading as the company revealed it had received a ...

On November 16, 2023, Kinnate Biopharma was surprised to receive a letter outlining a proposal for a potential acquisition of ...

On September 19, 2023, Jefferies analyst Roger Song expressed his positive outlook on Kinnate Biopharma (NASDAQ:KNTE), maintaining a Buy rating ...

Kinnate Biopharma has experienced a decline in its stock trading as a result of recent announcements regarding pipeline updates, a ...

On September 19, 2023, Kinnate Biopharma (NASDAQ: KNTE) received a downgrade from Wedbush analyst David Nierengarten. The analyst revised their ...

Kinnate Biopharma Inc. (KNTE) stands as a pioneering precision oncology company that is dedicated to developing selective small molecules that ...

As of September 18, 2023, Kinnate Biopharma (KNTE) has temporarily suspended the trading of its shares, leaving investors eagerly awaiting ...

Kinnate Biopharma Inc, a leading clinical-stage oncology company, has recently released its latest research report on KNTE. The company is ...

On August 8, 2023, Kinnate Biopharma, a renowned precision oncology company listed on NASDAQ under the ticker symbol KNTE, revealed ...

On May 18, 2023, Kinnate Biopharma stands as a leading biopharmaceutical company that specializes in the research and development of ...